In the United States, hydroxychloroquine falls under HS code 30049059. The Most Favored Nation (MFN) tariff rate for this code is 0%, as pharmaceuticals are generally duty-free. The U.S. has free trade agreements (FTAs) with several countries, but since the MFN rate is already 0%, preferential rates under FTAs do not further reduce tariffs for this product. Additionally, essential medicines like hydroxychloroquine are exempt from import duties.
The United Kingdom and Germany, as part of the European Union, also apply an MFN tariff rate of 0% for HS code 30049059, rendering pharmaceuticals duty-free. The EU has FTAs with various countries, but similar to the U.S., the 0% MFN rate means that preferential rates under these agreements do not further impact tariffs for hydroxychloroquine. Essential medicines are typically exempt from import duties within the EU.
In Australia, the MFN tariff rate for HS code 30049059 is 0%, making pharmaceuticals duty-free. Australia has FTAs with multiple countries, but the existing 0% MFN rate means that these agreements do not provide additional tariff reductions for hydroxychloroquine. Essential medicines are generally exempt from import duties in Australia.
For Thailand, Vietnam, Algeria, and Canada, specific MFN tariff rates and FTA provisions for HS code 30049059 vary. However, many countries offer duty exemptions or reduced rates for essential medicines, including hydroxychloroquine. Importers should consult the respective national customs authorities or the World Trade Organization (WTO) tariff databases for precise and up-to-date information on tariff rates and exemptions.
